IN8BIO, INC. — Director's Dealing 2021

Nov 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2021-11-19

Reporting Person: Goswami Trishna (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-19	Employee Stock Option (right to buy)	$6.80	A	250000	Acquired	2031-11-19	Common Stock (250000)	Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option shall vest on November 19, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.